Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity
Hafner, Marc, Mills, Caitlin E., Subramanian, Kartik, Chen, Chen, Chung, Mirra, Boswell, Sarah A., Everley, Robert A., Liu, Changchang, Walmsley, Charlotte S., Juric, Dejan, Sorger, Peter K.Language:
english
Journal:
Cell Chemical Biology
DOI:
10.1016/j.chembiol.2019.05.005
Date:
June, 2019
File:
PDF, 5.78 MB
english, 2019
File converter
More search results
More benefits 
